bioRxiv · 10.1101/2021.01.27.428394
Lysosomal-Immune Axis Is Associated with COVID 19 Disease Severity: Insights from Patient Single Cell Data
Abstract
SARS-COV-2 has become a leading cause of illness, hospitalizations, and deaths worldwide yet heterogeneity in disease morbidity remains a conundrum. In this study, we analyzed publicly available single-cell RNA-seq data from 75076 cells sequenced from clinically staged COVID-19 patients using a network approach and identified lysosomal-immune axis as a factor significantly associated with disease severity. Our results suggest modulation of lysosomal-immune pathways may present a novel drug-targeting strategy to attenuate SARS-Cov-2 infections.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Pande, R., Teeple, E., Huang, W., Klinger, K. W., Rajpal, D., Kumar, D.. 2021-01-27. Lysosomal-Immune Axis Is Associated with COVID 19 Disease Severity: Insights from Patient Single Cell Data. https://doi.org/10.1101/2021.01.27.428394
Cite the original work for its findings. Save a collection to share your selection of sources.